New £20m robot lab to speed up disease research

Formerly known as the Liverpool Robotic Infection Research Laboratory, the Liverpool Accelerate Laboratory is the UK’s first Category 3 robotic infection research facility combining high-containment laboratory infrastructure, AI, robotics and organoid technology to accelerate drug, vaccine and diagnostic development.

The new secure Containment Level 3 (CL3) laboratory is fitted with state-of-the-art liquid handling systems, robotics, and AI. It also meets Schedule Five biohazard security requirements, meaning it is future-fit for the safe handling of dangerous pathogens. The Liverpool Accelerate Laboratory is a high-security, steel-clad facility that responds to forthcoming changes in the Terrorism Act – making it a key UK biosecurity asset.

The BBC covered the launch and highlighted how the facility will bolster next generation drug and vaccine discovery. Click here to read the piece and find out more about the Liverpool Accelerate Laboratory.